Mapp Biopharmaceutical

A US-based biopharmaceutical company known for developing plant-derived monoclonal antibodies against filoviruses, including ZMapp for Zaire Ebola and MBP134 for pan-Ebola coverage including Bundibugyo.

1 of 1 entries (1 events, 0 interactions)